Cancer Science, 2026 Plasma Protein Analysis for Biomarker Discovery in Lung Cancer Treated With Atezolizumab Combination Therapy in J‐
TAIL
‐2 Goto Y., Nishio M., Ohashi K. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationPlasma | | | | |
JACC: Basic to Translational Science, 2026 Exercise Reverses Mental Stress–Induced Vascular Inflammation and Builds Stress Resilience Meyer-Lindemann U., Borbil K., Schwab M. et al. Olink Target 96 MouseCVDPathophysiologyMouse Plasma | | | | |
JCI Insight, 2026 NK cell cytotoxicity is transiently enhanced during acute malaria and modulated by the host microenvironment Xi P., Sandoz P., Lautenbach M. et al. Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma | | | | |
Cell Reports Medicine, 2026 Checkpoint blockade-related CNS adverse events are characterized by neurotoxic T helper cells with sustained neuroantigen reactivity Ma Y., Zhang A., Lin J. et al. Olink Target 96Olink Explore 3072/384NeurologyImmunotherapyPathophysiologyCSF | | | | |
Journal of Clinical Investigation, 2026 Lipoprotein(a)-Associated Proteomic Signature Predicts Cardiovascular Disease in Young Adults Goonewardena S., Yao S., Jurga T. et al. Olink Target 96Olink Explore 3072/384CVDPatient StratificationPlasma | | | | |
Clinical and Translational Science, 2026 GlycA
as an Effect Modifier of Protein–Mortality Associations: A Prospective Cohort Study Wang X., Qiao Z., Tao C. et al. Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma | | | | |
British Journal of Dermatology, 2026 A clinically actionable stratification of bullous pemphigoid using a disease activity score reveals a targetable inflammatory endotype Cao Z., Kong S., Ye J. et al. Olink Target 96Immunological & Inflammatory DiseasesDermatological DiseasesPatient StratificationSerum | | | | |
Communications Biology, 2026 Maternal-infant immune signatures in infants at risk for SARS-CoV-2-associated neurodevelopmental disorders Fajardo-Martinez V., Ferreira F., Salem G. et al. Olink Explore 3072/384NeurologyInfectious DiseasesObstetricsPathophysiologySerum | | | | |
Canadian Journal of Cardiology, 2026 Clinical and community factors' correlation with NT-proBNP in First Nations: a cross-sectional analysis of the CAHHM-FN cohort Marchand M., Labiba Z., Schulze K. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
PLOS One, 2026 Serum proteomic changes in atopic dermatitis patients treated with cyclosporine Olydam J., Litman T., Nijsten T. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesDermatological DiseasesPathophysiologySerum | | | | |
Psychoneuroendocrinology, 2026 Investigating the association of a selected inflammatory protein panel with suicide attempts in the PsyCourse Study: A pilot study Oraki Kohshour M., Budde M., Solomon P. et al. Olink Explore 3072/384NeurologyPatient StratificationPlasma | | | | |
The American Journal of Clinical Nutrition, 2026 Plasma proteomics enhances heart failure risk prediction among individuals with type 2 diabetes: a prospective cohort study Yu H., Zhang J., Qian F. et al. Olink Explore 3072/384Metabolic DiseasesCVDPatient StratificationPlasma | | | | |
Environment International, 2026 Association between urban heat island and type 2 diabetes risk: genetic and proteomic insights Ren J., Sun X., Zhang Z. et al. Olink Explore 3072/384Metabolic DiseasesEnvironmental Health & ToxicologyPathophysiologyPlasma | | | | |
Clinical Cancer Research, 2026 Gemcitabine plus Nivolumab with Carboplatin or Oxaliplatin in Cisplatin-Ineligible Patients with Metastatic Urothelial Carcinoma: A Randomized Phase II Trial Li Z., Izadmehr S., Hoffman-Censits J. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Brain, 2026 Machine learning model based on plasma proteomics for the identification of Parkinson’s disease Adewale B., Chia R., Moaddel R. et al. Olink Explore 3072/384NeurologyPathophysiologyPatient StratificationPlasma | | | | |
Biology of Sex Differences, 2026 Sex differences in proteomic response to ischemic stroke McLouth C., Hazelwood H., Frank J. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Translational Psychiatry, 2026 Divergence of C4A and C4B in first-episode psychosis: Insights from CSF and plasma immune profiling Arjmand S., Chaudhary M., Piehl F. et al. Olink Target 96NeurologyPathophysiologyPlasmaCSF | | | | |
Journal of Experimental & Clinical Cancer Research, 2026 Liquid biopsy reveals the immune status and protein profiles linked to CTC burden and clinical outcomes in metastatic breast cancer Kurma K., Bardol T., Mollevi C. et al. Olink Target 96OncologyPatient StratificationPlasma | | | | |
Cell Genomics, 2026 Interferon-related inflammaging links epigenetic age acceleration to multimorbidity Liu Z., Ziogas A., Zhang Y. et al. Olink Target 96AgingPathophysiologyPlasma | | | | |
JNCI: Journal of the National Cancer Institute, 2026 Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators Wang S., Viallon V., Biessy C. et al. Olink Target 96OncologyMetabolic DiseasesGynecologyPathophysiologyPlasma | | | | |